The novel approach of this peptide represents a significant advance in the care of type 2 diabetes. Different to existing drugs, tirzepatide impacts dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment